The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Overall Survival and Cause-Specific Mortality of Patients With Stage T1a,bN0M0 Breast Carcinoma
Abstract
Purpose: With mammographic screening, the frequency of diagnosis of stage T1a,bN0M0 breast cancer has increased. Prognosis after locoregional therapy and benefit from adjuvant systemic therapy are poorly defined. We reviewed T1a,bN0M0 breast cancer cases registered in the Surveillance, Epidemiology, and End Results (SEER) Program to investigate the impact of prognostic factors on breast cancer–specific (BCSM) and non–breast cancer–related mortality. Methods: We identified T1a,bN0M0 breast cancer cases registered in the SEER Program from 1988 to 2001, and used the Kaplan-Meier product limit method to describe overall survival (OS). We estimated the probabilities of death resulting from breast cancer and from other causes, and analyzed associations of patient and tumor characteristics with OS, BCSM, and non–breast cancer–related mortality using the log-rank test, Cox proportional hazards models, and a competing-risk model. We constructed nomograms to assist physicians in adjuvant therapy decision making. Results: We identified 51,246 T1a,bN0M0 cases. Median follow-up was 64 months (range, 1 to 167 months). Median age at diagnosis was 65 years (range, 20 to 101 years). Ten-year probabilities of all-cause mortality and BCSM were 24% and 4%, respectively. Characteristics associated with increased probability of BCSM included age younger than 50 years at diagnosis, high tumor grade, estrogen receptor–negative status, progesterone receptor–negative status, and fewer than six nodes removed at axillary dissection. The constructed nomograms allow a comparison of predicted breast cancer–specific survival and non-breast cancer–specific survival in individual patients. Conclusion: Overall, the prognosis of patients with T1a,bN0M0 breast cancer is excellent. However, subgroups of patients who are at higher risk of BCSM and who should be considered for adjuvant systemic therapy can be identified.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
American Joint Committee on Cancer (2002) · Springer eBooks · doi:10.1007/978-1-4757-3656-4 · Cited by 6,379
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885 · cited 2×
“The proportional hazards assumption was assessed graphically with residual plots and tested according to the method of Grambsch and Therneau.(21)”
MethodGooley, T. A., Leisenring, W., Crowley, J., & Storer, B. E. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990330)18:6<695::aid-sim60>3.0.co;2-o · Cited by 2,688
A class of rank test procedures for censored survival data
HARRINGTON, D. P., & FLEMING, T. R. (1982) · Biometrika · doi:10.1093/biomet/69.3.553 · Cited by 1,184
Jemal, A., Clegg, L. X., Ward, E., Ries, L. A. G., Wu, X., Jamison, P. M., Wingo, P. A., Howe, H. L., Anderson, R. N., & Edwards, B. K. (2004) · Cancer · doi:10.1002/cncr.20288 · Cited by 1,140
Ravdin, P. M., Siminoff, L. A., Davis, G. J., Mercer, M. B., Hewlett, J., Gerson, N., & Parker, H. L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.980 · Cited by 996
Accuracy of cancer death certificates and its effect on cancer mortality statistics.
Percy, C., Stanek, E., & Gloeckler, L. (1981) · American Journal of Public Health · doi:10.2105/ajph.71.3.242 · Cited by 704
Pepe, M. S., & Mori, M. (1993) · Statistics in Medicine · doi:10.1002/sim.4780120803 · Cited by 620
The Autopsy as a Measure of Accuracy of the Death Certificate
Kircher, T., Nelson, J., & Burdo, H. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511143132005 · Cited by 527
A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.
Rosen, P. R., Groshen, S., Saigo, P. E., Kinne, D. W., & Hellman, S. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.3.355 · Cited by 415
Rosen, P. P., Groshen, S., Kinne, D. W., & Norton, L. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.11.2090 · Cited by 295
Probabilities of Death From Breast Cancer and Other Causes Among Female Breast Cancer Patients
Schairer, C., Mink, P. J., Carroll, L., & Devesa, S. S. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh253 · Cited by 275
Fisher, B., Dignam, J., Tan-Chiu, E., Anderson, S., Fisher, E. R., Wittliff, J. L., & Wolmark, N. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.2.112 · Cited by 166
Chia, S., Speers, C. H., Bryce, C. J., Hayes, M. M., & Olivotto, I. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.070 · Cited by 144
Hanrahan, E. O., Valero, V., Gonzalez-Angulo, A. M., & Hortobágyi, G. N. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8035 · Cited by 142
Self-citationPercy, C., Miller, B. A., & Ries, L. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb32059.x · Cited by 108
Modeling the Effect of Tumor Size in Early Breast Cancer
Verschraegen, C. F., Vinh‐Hung, V., Cserni, G., Gordon, R., Royce, M., Vlastos, G., Tai, P., & Storme, G. A. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000150245.45558.a9 · Cited by 80
Walsh (1995) · doi:10.1002/1097-0142(19951201)76:11
Harrell, F., Jr. (1996) · doi:10.1002/(sici)1097-0258(19960229)15:4<361::aid-sim168>3.0.co;2-4
Cited by
(2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70385-6 · Cited by 919
Mehta, L. S., Watson, K. E., Barac, A., Beckie, T. M., Bittner, V., Cruz-Flores, S., Dent, S., Kondapalli, L., Ky, B., Okwuosa, T., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000556 · Cited by 848
Pantel, K., Alix-Panabières, C., & Riethdorf, S. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.44 · Cited by 643
Cardiovascular Disease Mortality Among Breast Cancer Survivors
Bradshaw, P. T., Stevens, J., Khankari, N., Teitelbaum, S. L., Neugut, A. I., & Gammon, M. D. (2016) · Epidemiology · doi:10.1097/ede.0000000000000394 · Cited by 443
Predictors of Competing Mortality in Advanced Head and Neck Cancer
Mell, L. K., Dignam, J. J., Salama, J. K., Cohen, E. E. W., Polite, B. N., Dandekar, V., Bhate, A. D., Witt, M. E., Haraf, D. J., Mittal, B. B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.9288 · Cited by 433
Metadata
- Authors
- Hanrahan, E. O., Gonzalez-Angulo, A. M., Giordano, S. H., Rouzier, R., Broglio, K. R., Hortobagyi, G. N., & Valero, V.
- Venue
- Journal of Clinical Oncology
- Published
- 2007-11-01
- Volume
- 25
- Issue
- 31
- Pages
- 4952-4960
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2106366706
- Cited by
- 315
- References
- 22
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.